<html>
<head>PUBMED IDs for Ep-CAM</head>
<body bgcolor='#C5F0F2'><h1>Ep-CAM</h1><a href='https://pubmed.ncbi.nlm.nih.gov/8163559/'>Ep-CAM: a human epithelial antigen is a homophilic cell-cell adhesion molecule.</a> April 1  1994<br><a href='https://pubmed.ncbi.nlm.nih.gov/10096296/'>A recombinant, fully human monoclonal antibody with antitumor activity constructed from phage-displayed antibody fragments.</a> March 30  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/10473805/'>An EGP-2/Ep-CAM-expressing transgenic rat model to evaluate antibody-mediated immunotherapy.</a> September 4  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/10606205/'>The biology of the 17-1A antigen (Ep-CAM).</a> December 22  1999<br><a href='https://pubmed.ncbi.nlm.nih.gov/10639329/'>Targets of extinction: identification of genes whose expression is repressed as a consequence of somatic fusion between cells representing basal and luminal mammary epithelial phenotypes.</a> January 20  2000<br><a href='https://pubmed.ncbi.nlm.nih.gov/11223068/'>Design and application of diabodies, triabodies and tetrabodies for cancer targeting.</a> February 27  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11259604/'>Epidermal growth factor-like repeats mediate lateral and reciprocal interactions of Ep-CAM molecules in homophilic adhesions.</a> March 22  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11315510/'>In vitro characterisation of a monovalent and bivalent form of a fully human anti Ep-CAM phage antibody.</a> April 24  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11358833/'>The epithelial glycoprotein 2 (EGP-2) promoter-driven epithelial-specific expression of EGP-2 in transgenic mice: a new model to study carcinoma-directed immunotherapy.</a> May 19  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11439361/'>Expression of genetic markers in lymph node metastases compared with their primary tumours in head and neck cancer.</a> July 6  2001<br><a href='https://pubmed.ncbi.nlm.nih.gov/11875747/'>A fully human anti-Ep-CAM scFv-beta-glucuronidase fusion protein for selective chemotherapy with a glucuronide prodrug.</a> March 5  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12100028/'>Antigenic and immunologic characterization of an allogeneic colon carcinoma vaccine.</a> July 9  2002<br><a href='https://pubmed.ncbi.nlm.nih.gov/12695858/'>Adenocarcinoma cells exposed in vitro to Navelbine or Taxol increase Ep-CAM expression through a novel mechanism.</a> April 16  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12790324/'>Minimal residual disease in breast cancer and gynecological malignancies: phenotype and clinical relevance.</a> June 7  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12844224/'>Expression of MUC 1 and Ep-CAM in Merkel cell carcinomas: implications for immunotherapy.</a> July 5  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/12855617/'>Immunization of colorectal carcinoma patients with a recombinant canarypox virus expressing the tumor antigen Ep-CAM/KSA (ALVAC-KSA) and granulocyte macrophage colony- stimulating factor induced a tumor-specific cellular immune response.</a> July 12  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/15240533/'>Overexpression of the cell adhesion molecules DDR1, Claudin 3, and Ep-CAM in metaplastic ovarian epithelium and ovarian cancer.</a> July 9  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15243630/'>Use of the EGP-2/Ep-CAM promoter for targeted expression of heterologous genes in carcinoma derived cell lines.</a> July 10  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15305371/'>Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: identification of candidate molecular markers for ovarian cancer diagnosis and therapy.</a> August 12  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15328177/'>Vaccination with Ep-CAM protein or anti-idiotypic antibody induces Th1-biased response against MHC class I- and II-restricted Ep-CAM epitopes in colorectal carcinoma patients.</a> August 26  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15382049/'>Targeting human Ep-CAM in transgenic mice by anti-idiotype and antigen based vaccines.</a> September 24  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15472903/'>Expression patterns of potential therapeutic targets in prostate cancer.</a> October 9  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15567937/'>High Ep-CAM expression is associated with poor prognosis in node-positive breast cancer.</a> November 30  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15567936/'>HER-2/neu as a predictive marker in a population of advanced breast cancer patients randomly treated either with single-agent doxorubicin or single-agent docetaxel.</a> November 30  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/15570423/'>T-cell receptor BV gene usage in colorectal carcinoma patients immunised with recombinant Ep-CAM protein or anti-idiotypic antibody.</a> December 1  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/16096650/'>The carcinoma-specific epithelial glycoprotein-2 promoter controls efficient and selective gene expression in an adenoviral context.</a> August 13  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16302733/'>Preparation of human IgG and IgM monoclonal antibodies for MK-1/Ep-CAM by using human immunoglobulin gene-transferred mouse and gene cloning of their variable regions.</a> November 24  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16404366/'>Frequent high-level expression of the immunotherapeutic target Ep-CAM in colon, stomach, prostate and lung cancers.</a> January 13  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/16624485/'>Methylation status of the Ep-CAM promoter region in human breast cancer cell lines and breast cancer tissue.</a> April 21  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17213811/'>DNA methylation and histone modification regulate silencing of epithelial cell adhesion molecule for tumor invasion and progression.</a> January 11  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/17361206/'>Loss of membranous Ep-CAM in budding colorectal carcinoma cells.</a> March 16  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/19019843/'>Cell discohesion and multifocality of carcinoma in situ of the bladder: new insight from the adhesion molecule profile (e-cadherin, Ep-CAM, and MUC1).</a> November 21  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19098912/'>Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3' exons of TACSTD1.</a> January 24  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/19302955/'>Expression of epithelial cell adhesion molecule and pituitary tumor transforming gene in adamantinomatous craniopharyngioma and its correlation with recurrence of the tumor.</a> May 20  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19401692/'>Activation of Wnt/beta-catenin signalling pathway induces chemoresistance to interferon-alpha/5-fluorouracil combination therapy for hepatocellular carcinoma.</a> June 3  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20352488/'>Ep-CAM RNA expression predicts metastasis-free survival in three cohorts of untreated node-negative breast cancer.</a> May 3  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20461151/'>Genome-wide changes accompanying the knockdown of Ep-CAM in retinoblastoma.</a> August 26  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20473768/'>Expression of the GA733 gene family and its relationship to prognosis in pulmonary adenocarcinoma.</a> August 21  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20617339/'>CD99-positive large cell neuroendocrine carcinoma with rearranged EWSR1 gene in an infant: a case of prognostically favorable tumor.</a> September 30  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20940408/'>H3K9 histone methyltransferase G9a promotes lung cancer invasion and metastasis by silencing the cell adhesion molecule Ep-CAM.</a> December 14  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21079580/'>New prognostic and predictive factors in breast cancer.</a> May 7  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/22450763/'>Cellular apoptosis susceptibility (chromosome segregation 1-like, CSE1L) gene is a key regulator of apoptosis, migration and invasion in colorectal cancer.</a> January 6  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/22552364/'>Downregulation of Prominin 1/CD133 expression in colorectal cancer by NSAIDs following short-term preoperative treatment.</a> September 1  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/25969565/'>Metastasis-associated protein 2 (MTA2) promotes the metastasis of non-small-cell lung cancer through the inhibition of the cell adhesion molecule Ep-CAM and E-cadherin.</a> October 20  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26028961/'>Construction of interference vector targeting Ep-CAM gene and its effects on colorectal cancer cell proliferation.</a> February 16  2015<br></body></html>
